(Q40303565)

English

Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial

scientific article published on 31 January 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

adult acute myeloid leukemia

1 reference

based on heuristic

inferred from title

11

object named as

Pierre Fenaux

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

14

object named as

Hervé Dombret

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Giovanna Cannas

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Cécile Pautas

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Emmanuel Raffoux

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Bruno Quesnel

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Stéphane de Botton

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Thierry de Revel

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Oumedaly Reman

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Claude Gardin

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Mohamed Elhamri

9

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Nicolas Boissel

10

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Mauricette Michallet

12

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sylvie Castaigne

13

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Xavier Thomas

15

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

31 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1068-1076

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Bacterial infection and acute myeloblastic leukaemia: An analysis of two hundred patients undergoing intensive remission induction therapy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Which AML subsets benefit from leukemic cell priming during chemotherapy? Long-term analysis of the ALFA-9802 GM-CSF study.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Therapy of small cell lung cancer: anything new?

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Bacteraemia in febrile neutropenic cancer patients

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Is BAL useful in patients with acute myeloid leukemia admitted in ICU for severe respiratory complications?

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). The MCR Childhood Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

The cost of treating systemic fungal infections

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.636812

21 January 2018

Identifiers

10.3109/10428194.2011.636812

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40303565&oldid=1894215364"